Federal Home Loan Mortgage Corp
Change company Symbol lookup
Select an option...
FMCKN Federal Home Loan Mortgage Corp
TWODY Taylor Wimpey PLC
ALKS Alkermes Plc
CPTNW Cepton Equity Warrant Exp 10th Feb 2027 *W EXP 02/10/2027
APPF Appfolio Inc
FMN Federated Hermes Premier Municipal Inc
USCTU TKB Critical Technologies 1
SIEGY Siemens AG
FDBC Fidelity D&D Bancorp Inc
$BUKCHET Bloomberg Coffee Subindex Euro
Go

Financials : Thrifts & Mortgage Finance | Small Cap Value
Company profile

Federal Home Loan Mortgage Corporation is a government-sponsored enterprise (GSE). The Company is engaged in purchasing residential mortgage loans originated by lenders. The Company also invests in mortgage loans and mortgage-related securities. The Company operates through two segments: Single-Family and Multifamily. The Single-Family segment includes purchase, securitization, and guarantee of single-family loans, its investments in single-family loans and mortgage-related securities, the management of Single-Family mortgage credit risk and market risk, and any results of its treasury function that are not allocated to each segment. The Multifamily segment includes purchase, securitization, and guarantee of multifamily loans, its investments in multifamily loans and mortgage-related securities, and the management of multifamily mortgage credit risk and market risk.

This security is a preferred stock
Closing Price
$1.90
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Heavy Day)
Volume:
32,882

10-day average volume:
6,435
32,882

AbbVie to Present at the Piper Sandler Healthcare Conference

9:00 am ET November 22, 2022 (PR Newswire) Print

AbbVie (NYSE: ABBV) will participate in the Piper Sandler 34th Annual Healthcare Conference on Thursday, December 1, 2022. Rob Michael, vice chairman and president, Jeffrey R. Stewart, executive vice president, commercial operations, Scott Reents, senior vice president and chief financial officer, and Tom Hudson senior vice president, R&D and chief scientific officer, will present at 8:30 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women's health, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTubeand LinkedIn.

https://c212.net/c/img/favicon.png?sn=CG43851&sd=2022-11-22

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-piper-sandler-healthcare-conference-301684500.html

SOURCE AbbVie

https://rt.newswire.ca/rt.gif?NewsItemId=CG43851&Transmission_Id=202211220900PR_NEWS_USPR_____CG43851&DateId=20221122

comtex tracking

COMTEX_419480666/1005/2022-11-22T09:00:27

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.